Sort
48,018 grants matching “immunotherapy”
Manufacturing of New Batch AV-1959D Drug Product and Placebo for Phase 1 Trial
$699,000Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2023 · AG
COOPERATIVE HUMORAL &CELLULAR IMMUNITY AGAINST HIV/SIV
$698,992Scripps Research Institute · R01 · FY2002 · AI
Bronx-Lebanon Hospital Center Pediatric ACTU
$698,974Bronx-Lebanon Hosp Ctr (Bronx, Ny) · U01 · FY2002 · AI
Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma
$698,751Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
$698,575Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Mechanisms of Effective Humoral Immune Responses to HIV-1
$698,550Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$698,544Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2022 · CA
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction
$698,487Gal Shafirstein · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
COMPLEMENT INHIBITION IN THE IMMUNOTHERAPY OF BREAST CANCER
$698,332Texas Tech University Health Sciences Center · · FY2012 · Department of Defense
Role of Novel Cytokine Secretoglobin (SCGB) 3A2 in Lung
$698,320Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$698,268Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Core B: Molecular Pathology and Bioinformatics Core
$698,153Michael F. Berger · Sloan-Kettering Inst Can Research · P01 · FY2025 · CA
Nanotechnology-based cardiovascular vaccines
$698,017Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2025 · HL
Deciphering the Critical Determinants of Enteric and Tumor Niche Colonization by Microbes in Colorectal Cancer
$697,763Christopher D Johnston · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Antigenic determinants of asthma-associated allergens for design of immunotherapy.
$697,759Anna Pomes · Indoor Biotechnologies · R01 · FY2016 · AI
Attacking the Immunopeptidome of Ewing Sarcoma
$697,731Crystal Mackall · Stanford University · U01 · FY2025 · CA
Safety and Efficacy of SHIV Vaccine in Macaques
$697,674University Of Kansas Medical Center · R01 · FY2002 · AI
Evolution of gliomas during treatment and resistance
$697,603Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Clinical Trials to Evaluate the Safety and Antiviral Effects of High Affinity Gag
$697,584Carl H. June · University Of Pennsylvania · U19 · FY2012 · AI
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
$697,539Anna Karolina Palucka · Jackson Laboratory · R01 · FY2017 · CA
Vaccine and radiation for the therapy of human cancers
$697,290James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$697,290James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
$697,232Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$697,195Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$697,166Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA